drugset / Trial / NCT06842966
Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to evaluate the efficacy, safety, and tolerability of the drug 4-MUST at various doses compared to placebo in patients with chronic cholecystitis and biliary dyskinesia
Timeline
- Start
- 2024-10-17
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 4-MUST | Unknown | 128 mg | — |
| Subject | 4-MUST | Unknown | 256 mg | — |
| Subject | 4-MUST | Unknown | 384 mg | — |